Meridian's Omaha, NE, location serves as the company's international headquarters and largest independent research facility. Under the leadership of medical director and principal investigator Brandon J. Essink, MD, Meridian's Omaha site conducts research for a broad range of investigational treatments. Studies at this site explore vaccines and medicines developed to treat migraines, acne, depression, high cholesterol, and other conditions.
For more information about joining a study in Omaha, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
Participating in a study is an important decision — we’re here to help you before, during, and after studies.
Phone: (402) 934-7563
Meridian Clinical Research
3319 N 107th St
Omaha, NE 68134
Meet the Physician
Brandon J. Essink, MD, CPI
Dr. Brandon Essink has served as a principal investigator at Meridian since 2003. In his role, Dr. Essink directs clinical practice operations at Meridian’s dedicated research center in Omaha, NE. He is frequently selected to lead pioneering vaccine research programs because of his extensive experience in the field and the superb track record sites have maintained under his guidance.
Dr. Essink earned his BS from the University of Nebraska in Lincoln, NE, and attended medical school at the University of Nebraska Medical Center, in Omaha, NE, graduating in 2001. He completed his residency in Family Practice at the University of Nebraska Medical Center in 2003 and a Family Practice Procedural Fellowship in 2004. He has been board certified in family practice since 2003 and has practiced family medicine since 2004.